T he effectiveness of thrombectomy in large vessel occlusion strokes with and without tandem extracranial disease is comparable.
setting of large vessel occlusion strokes patients with anterior circulation tandem occlusion. 3 In a recent meta-analysis, Sadeh-Gonik et al 3 reported an intracerebral hemorrhagic and symptomatic hemorrhage rates of 24% and 8%, respectively. Although HI has been usually considered benign, some studies found that HI was associated with higher risks of worse outcome in isolated intracranial occlusions treated with thrombectomy. 4 We aim to evaluate the incidence, predictors, and clinical relevance of intracerebral hemorrhagic transformation subtypes in tandem large vessel occlusion strokes patients treated by thrombectomy in a large multicenter series.
Methods
All data and materials have been made publicly available in a public repository and can be accessed by request from Dr Gory.
Patient Selection
Methods of TITAN (Thrombectomy in Tandem Lesions) collaboration have been previously reported. 5 Inclusion criteria encompassed acute ischemic stroke patients with a proven tandem occlusion of the anterior circulation on digital subtraction angiography, defined as a proximal intracranial occlusion and an extracranial severe internal carotid artery (ICA) lesion (complete occlusion or stenosis ≥90% North American Symptomatic Carotid Endarterectomy Trial). All patients had an imaging at 24 hours after treatment onset to assess for hemorrhagic complications. We included here only patients with atherosclerotic cause. The local institutional review boards approved the study and waived the need for patient consent.
Outcomes
Cerebral hemorrhages were classified as HI or PH within 24 hours of thrombectomy according to the European Cooperative Acute Stroke Study II criteria. Successful reperfusion was defined as modified Thrombolysis In Cerebral Infarction grade 2b-3 at the end of the procedure. Favorable outcome was defined as a modified Rankin Scale score ≤2 at 90 days.
Statistical Analysis
Patients were divided into 3 groups according to occurrence or not of HI and PH within 24 hours after thrombectomy. The detailed methodology of the statistical analysis is reported in the online-only Data Supplement.
Results
Of the 267 tandem patients with available data on hemorrhagic transformation, there were 66 (24.7%) HI (n=31 HI1, and n=35 HI2) and 38 (14.2%) PH (n=24 PH1, and n=14 PH2).
Predictors of Hemorrhagic Transformation Subtypes
Patient's treatment characteristics and outcomes are shown before handling missing data by multiple imputations in Table  I in the online-only Data Supplement. After handling missing data, diabetes mellitus, admission National Institutes of Health Stroke Scale, initial imaging modality (magnetic resonance imaging versus computed tomography), Alberta Stroke Program Early CT Scores <7, extracranial ICA lesion (stenosis ≥90% versus complete occlusion), site of intracranial occlusion (ICA versus middle cerebral artery), prior use of intravenous thrombolysis, and use of clopidogrel differed between the study groups at P<0.20, and were included in multivariable multinomial logistic regression analysis (Table II in the onlineonly Data Supplement). Intracranial ICA occlusion, diabetes mellitus, no prior use of intravenous thrombolysis, and extracranial complete ICA occlusion were the independent predictors of HI (Figure) . For PH, similar predictors were found with addition of stroke severity measured by baseline National Institutes of Health Stroke Scale and Alberta Stroke Program Early CT Scores <7. When HI and PH were pooled together, independent predictors of hemorrhagic transformation were reported in the Table III in 
Clinical Relevance of Hemorrhagic Transformation
Distribution of 90-day modified Rankin Scale according to the study groups is available in Figure in the online-only Data Supplement. Using patients without hemorrhagic transformation as reference, patients with PH were associated with a decreased rate of favorable outcome (odds ratio, 0.26; 95% CI, 0.11-0.58; P<0.001), but not patients with HI (odds ratio, 0.81; 95% CI, 0.44-1.47; P=0.48). Similar findings were found when overall distribution of modified Rankin Scale was analyzed (Table) . However, after adjustment for predictors of hemorrhagic transformation, the detrimental effect of PH on Figure. Results of multivariate analysis assessing independent predictors of hemorrhagic infarction (HI) and parenchymal hematoma (PH). Odds ratios and P Value were calculated after handling missing data by multiple imputations. ASPECTS indicates Alberta Stroke Program Early CT Scores; CT, computed tomography; ICA, internal carotid artery; IV-tPA, intravenous tissue-type plasminogen activator; MRI, magnetic resonance imaging; and NIHSS, National Institutes of Health Stroke Scale.
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functional outcome was attenuated and remained significant only in shift analysis with an adjusted common odds ratio for 1-point modified Rankin Scale improvement of 0.39 (95% CI, 0.19-0.82; P=0.011). Conversely, only occurrence of PH was significantly associated with increased mortality rate with an adjusted odds ratio of 2.63 (95% CI, 1.05-6.59; P=0.039).
Discussion
In the TITAN cohort, we observed similar rates than in isolated intracranial occlusion strokes reported in the literature. Tandem occlusions constitute a significant portion thrombectomy cases, and the major problem in tandem management is the safety of carotid stenting in association with antiplatelet therapy because of the considered high risk of intracranial bleeding in freshly reperfused brain infarction. Our data supported the notion that carotid stenting and antiplatelet therapy administration in acute phase of stroke treated by thrombectomy seems safe, with or without prior intravenous thrombolysis. Considering the fact that carotid stenting was also predictor of successful reperfusion, 3, 5, 6 the approach associating thrombectomy and carotid stenting may be the best therapeutic option for therapy of tandem large vessel occlusion strokes.
To date, there is limited data on the risk of HI and PH after thrombectomy, and especially in the setting of tandem stroke. We found that intracranial ICA occlusion, diabetes mellitus, no prior use of intravenous thrombolysis, and extracranial ICA occlusion were predictors of HI. For PH, similar predictors were found with addition of higher baseline National Institutes of Health Stroke Scale and Alberta Stroke Program Early CT Scores <7. Moreover, considering our data, occurrence of HI after tandem thrombectomy was not associated with unfavorable outcome in the majority of cases, in contrary to the literature data considering the not benign nature of HI, and different predictors for HI and PH. 4 The present findings are derived from observational analyses, which are subject to well-known limitations. Treatment strategy was left to the interventionist discretion, and drug doses and administration times were unknown. The lack of an independent reading of brain imaging and clinical outcomes leads to bias.
Conclusions
Incidence of HI and PH in tandem strokes was similar than those reported in isolated intracranial occlusions thrombectomy trial. Intracranial ICA occlusion, diabetes mellitus, no prior use of intravenous thrombolysis, and extracranial ICA occlusion were predictors of HI and PH, whereas extracranial carotid stenting and antiplatelet therapy were not, supporting aggressive treatment of tandem occlusions.
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